Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Ginkgo Bioworks Holdings Inc. Class A

Doric Nimrod Air Three ( ($GB:DNA3) ) has shared an announcement. Doric Nimrod Air Three Limited has completed the sale of its Airbus A380-861 airc...

Doric Nimrod Air Three to Redeem Shares Following Aircraft Sales

Doric Nimrod Air Three ( ($GB:DNA3) ) just unveiled an update. Doric Nimrod Air Three Limited has released its unaudited interim financial report f...

Doric Nimrod Air Three Releases Interim Financial Report

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) has issued an announcement. Medicenna Therapeutics Corp announced updated clinical trial results for MD...

Medicenna’s MDNA11 Shows Promising Results in Advanced Tumor Trials

Medicenna Therapeutics Corp ( ($TSE:MDNA) ) has shared an update. Medicenna Therapeutics announced a live webinar to discuss updated clinical data ...

Medicenna Therapeutics to Host Webinar on MDNA11 Clinical Data

Doric Nimrod Air Three ( ($GB:DNA3) ) has issued an update. Doric Nimrod Air Three Limited held its annual general meeting on December 4, 2025, whe...

Doric Nimrod Air Three Limited Announces AGM Results

An announcement from Doric Nimrod Air Three ( ($GB:DNA3) ) is now available. Doric Nimrod Air Three Limited has announced the posting of its Notice...

Market Cap	$579.24M	P/E Ratio	N/A
52W High	$17.58	52W Low	$5.00
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	42.0%	52W Position	34.5%
Overall Score	51	Value Score	60
Quality Score	44	Technical Score	50

EPS Current Est	$-5.94	EPS Next Est	$-4.33
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DNA	$9.34	-5.66%	893.43K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DNA	$9.34	-5.7%	893.43K
3
4
5
6

DNA

DNA

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel

Get Ginkgo Bioworks Holdings Inc. Class A Data in Excel